“Health-Related Quality of Life Burden in Scleroderma Patients Treated With Two Different Intravenous Iloprost Regimens”. Reumatismo, vol. 71, no. 2, July 2019, pp. 62-67, https://doi.org/10.4081/reumatismo.2019.1190.